You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed arti
Submission declined on 14 July 2026 by Theroadislong (talk).
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
|
GeneGoCell is a San Diego-based biotechnology company specializing in customized next-generation sequencing (NGS) and flow cytometry services for the cell and gene therapy (CGT) industry. Founded in 2020, the company operates GxP- and CLIA-compliant laboratories accredited to ISO/IEC 17025:2017 standards and focuses on genome editing verification, genotoxicity testing, and precision analytics that support clients from early research through clinical development.
GeneGoCell provides fast-turnaround, fully customized solutions with an emphasis on regulatory compliance, data quality, and responsive project management. Its proprietary platforms include client information management systems (CIMS), laboratory information management systems (LIMS), and bioinformatics pipelines designed for sample-to-report workflows in the precision medicine sector.
The company is headquartered in the Rancho Bernardo area of San Diego, California, and maintains a team of 11–50 employees.
GeneGoCell Inc. was founded in November 2020 by Dr. Elizabeth Zhang to address the growing demand for rapid, high-quality, compliant testing services in the cell and gene therapy field. Zhang-Chen serves as Chief Executive Officer and brings expertise in immunology, quality management, and business (PhD in immunology from the University of Kansas Medical Center; MBA from UC San Diego’s Rady School of Management; certifications including SCYM(ASCP)CM and CMQ/OE).
The company was established to fill a market gap for fast, reliable genotoxicity and genome editing verification services that help accelerate regulatory approval while maintaining rigorous safety and quality standards.
GeneGoCell offers end-to-end customized services centered on Next-Generation Sequencing (NGS) and Flow Cytometry, with particular strength in genome editing verification for CGT applications.
Custom panel design, development, and analysis with compliant reporting.
The company emphasizes rapid turnaround (approximately 90% of NGS projects completed within one week and nearly all within two weeks, with expedited options as fast as three days), tailored assays/workflows, and dedicated project managers who provide responsive support.
GeneGoCell maintains GxP (GMP and GLP), CLIA compliance, and ISO/IEC 17025:2017 accreditation (with ANAB recognition). An experienced quality assurance team reviews all testing and analysis to support regulatory submissions and clinical-stage work. These credentials enable the company to serve clients pursuing IND-enabling studies and clinical trials in the cell and gene therapy space.
Proprietary informatics systems (CIMS, LIMS, and advanced bioinformatics pipelines) ensure traceability, data integrity, and efficient sample-to-report delivery.
GeneGoCell’s stated mission is “To provide fast-turnaround, top-quality, customized services via innovating genomics and cellular technologies.” Its core values are summarized as Love | Trust | Commitment, which the company describes as the foundations of its operations and client partnerships.
Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.
- provide significant coverage: discuss the subject in detail, excluding routine coverage like product launches, staff appointments, or financial reports and listings in databases or listicles;
- are reliable: from reputable outlets with editorial oversight;
- are independent: not connected to the subject, such as press releases, the subject's own website, or sponsored content.
Please add references that meet all three of these criteria. If none exist, the subject is not yet suitable for Wikipedia.